Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Sell
42
ERFSF Quote, Financials, Valuation and Earnings
Last price:
$69.30
Seasonality move
:
4.2%
Day range:
$64.98 - $67.82
52-week range:
$46.37 - $83.02
Dividend yield:
1.86%
P/E ratio:
26.55x
P/S ratio:
1.61x
P/B ratio:
57.94x
Volume:
3K
Avg. volume:
1.8K
1-year change:
28.39%
Market cap:
$11.6B
Revenue:
$7.5B
EPS (TTM):
$2.55
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Eurofins Scientific SE has -- downside to fair value with a price target of -- per share.
ERFSF vs. S&P 500
-
Over the past 5 trading days, Eurofins Scientific SE has underperformed the S&P 500 by -3.87% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Eurofins Scientific SE does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Eurofins Scientific SE has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Eurofins Scientific SE reported revenues of --.
Earnings Growth
-
Eurofins Scientific SE has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Eurofins Scientific SE reported earnings per share of --.
Enterprise value:
13B
EV / Invested capital:
--
Price / LTM sales:
1.61x
EV / EBIT:
15.71x
EV / Revenue:
1.67x
PEG ratio (5yr expected):
6.11x
EV / Free cash flow:
17.45x
Price / Operating cash flow:
16.83x
Enterprise value / EBITDA:
8.07x
Gross Profit (TTM):
$826.2M
Return On Assets:
4.06%
Net Income Margin (TTM):
6.06%
Return On Equity:
8.55%
Return On Invested Capital:
5.27%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2010-12-31 | 2011-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $252.8M | $327.5M | |
| Gross Profit | -- | -- | -- | $30.6M | $42.1M | |
| Operating Income | -- | -- | -- | $30.6M | $42.1M | |
| EBITDA | -- | -- | -- | $44.6M | $58M | |
| Diluted EPS | -- | -- | -- | $0.08 | $0.20 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $2.8B | $2.8B | $2.8B | $3.1B | |
| Total Assets | $10.3B | $10.7B | $11.2B | $11.6B | $12.4B | |
| Current Liabilities | $2.1B | $2.1B | $2B | $2B | $2.4B | |
| Total Liabilities | $5.4B | $5.7B | $5.7B | $5.9B | $6.9B | |
| Total Equity | $4.9B | $5B | $5.5B | $5.7B | $5.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2010-12-31 | 2011-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $70.8M | $77.9M | |
| Cash From Investing | -- | -- | -- | -$21.6M | -$32.6M | |
| Cash From Financing | -- | -- | -- | -$17.6M | -$24.5M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ERFSF
Sector
Market Cap
$11.6B
$28.5M
Price % of 52-Week High
78.9%
51.82%
Dividend Yield
1.86%
0%
Shareholder Yield
4.29%
-1.4%
1-Year Price Total Return
28.39%
-21.29%
Beta (5-Year)
0.637
0.519
Dividend yield:
1.86%
Annualized payout:
$0.54
Payout ratio:
-46.98%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$68.26
200-day SMA
Sell
Level
$67.74
Bollinger Bands (100)
Sell
Level
69.43 - 77.39
Chaikin Money Flow
Buy
Level
63.2K
20-day SMA
Sell
Level
$68.37
Relative Strength Index (RSI14)
Sell
Level
41.58
ADX Line
Sell
Level
14.96
Williams %R
Buy
Level
-91.5834
50-day SMA
Sell
Level
$70.41
MACD (12, 26)
Sell
Level
-0.80
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
183.3K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1535)
Sell
CA Score
(Annual)
Level (-0.431)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.2959)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.
Stock Forecast FAQ
In the current month, ERFSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ERFSF average analyst price target in the past 3 months is --.
-
Where Will Eurofins Scientific SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Eurofins Scientific SE share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Eurofins Scientific SE?
Analysts are divided on their view about Eurofins Scientific SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Eurofins Scientific SE is a Sell and believe this share price will rise from its current level to --.
-
What Is Eurofins Scientific SE's Price Target?
The price target for Eurofins Scientific SE over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ERFSF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Eurofins Scientific SE is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ERFSF?
You can purchase shares of Eurofins Scientific SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Eurofins Scientific SE shares.
-
What Is The Eurofins Scientific SE Share Price Today?
Eurofins Scientific SE was last trading at $69.30 per share. This represents the most recent stock quote for Eurofins Scientific SE. Yesterday, Eurofins Scientific SE closed at $65.50 per share.
-
How To Buy Eurofins Scientific SE Stock Online?
In order to purchase Eurofins Scientific SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ERFSF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ERFSF
Sector
P/E ratio
26.55x
23.52x
PEG ratio
6.11x
-0.01x
P/B ratio
57.94x
1.82x
Price / LTM sales
1.61x
1.60x
Growth Metrics
ERFSF
Sector
Revenue growth
--
4.8%
Earnings growth
--
11.11%
Revenue (5-year growth)
8.04%
6.45%
Earnings forecast
--
-$0.20
Profitability
ERFSF
Sector
Profitability FY 2024
$858.9M
$3.5M
Return on invested capital
5.27%
-31.16%
Return on assets
4.06%
-27.72%
Return on equity
8.55%
-37.13%
Earnings Date
Last Earnings Date
Jul
23
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Oct
22
Balance Sheet
ERFSF
Sector
Total cash
$883.3M
$27M
Short term investments
--
$25.7M
Total assets
$11.3B
$79.7M
Long term debt
--
$3.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Stock Ideas
Buy
64
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
60
OLMA alert for Dec 10
Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.
Buy
84
TSAT alert for Dec 10
Telesat Corp. [TSAT] is up 3.07% over the past day.
Buy
54
GDXU alert for Dec 10
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 4.83% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
